All Markus Hoffmann articles
-
NewsIs the licensed Zaire ebolavirus vaccine suitable to combat the current Bundibugyo ebolavirus outbreak?
Researchers provide evidence of possible cross-protection through an already licensed Zaire ebolavirus vaccine.
-
NewsPirola variant of Covid rediscovers entry pathway into lung cells
Researchers have discovered that the Pirola variant enters lung cells with high efficiency and uses the cellular enzyme TMPRSS2 for entry, thereby exhibiting parallels to variants Alpha, Beta, Gamma and Delta.
-
NewsNew SARS-CoV-2 variant Eris on the rise
The EG.5 lineage of SARS-CoV-2, known as Eris, which has been spreading globally, has been found to be able to escape neutralizing antibodies better than other currently circulating SARS-CoV-2 lineages.
-
NewsOmicron subvariant BA.5 efficiently infects lung cells
Over the course of evolution of Omicron subvariants, viruses may arise that regain the ability to effectively spread in the lung and cause severe illness in risk patients and people with insufficient immunity, a new study suggests.